Defunct Company
Total Trials
14
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,861
NCT00725686
Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2007
Completion: Nov 30, 2010
NCT00554359
A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
Start: Aug 31, 2007
NCT00683553
A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)
Start: May 31, 2008
Completion: Sep 30, 2010
NCT00701181
Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema
Phase: Phase 2
Start: Jun 30, 2008
Completion: Jan 31, 2011
NCT00802347
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Phase: Phase 1/2
Start: Dec 31, 2008
Completion: May 31, 2014
NCT00713518
Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).
Start: Nov 30, 2009
Completion: Jul 31, 2011
NCT01064505
Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
Start: Feb 28, 2010
Completion: Apr 30, 2013
NCT01445899
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Start: Feb 29, 2012
Completion: Nov 30, 2013
NCT01965106
Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
Start: Dec 31, 2013
Completion: Jul 31, 2015
NCT02610283
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
Start: Dec 31, 2015
Completion: Apr 30, 2018
NCT02341560
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Phase: Phase 2/3
Start: Feb 24, 2016
Completion: Jul 1, 2019
NCT02610296
QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Phase: Phase 3
Start: Mar 1, 2016
Completion: Jan 8, 2019
NCT03510897
QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
Start: Jun 29, 2018
Completion: Apr 12, 2021
NCT04654221
Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery
Phase: N/A
Start: Feb 21, 2020
Completion: Mar 26, 2021